Funder: National Institutes of Health
Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports translational and clinical research to advance precision therapeutics for pregnant/lactating persons, fetuses, neonates, and children, including those with disabilities.
Key Information: Clinical trial proposals are optional; foreign and domestic organizations are eligible; Data Management and Sharing Plan required.